Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.

Vonderheide, R H; Schultze, J L; Anderson, K S; Maecker, B; Butler, M O; Xia, Z; Kuroda, M J; von Bergwelt-Baildon, M S; Bedor, M M; Hoar, K M; Schnipper, D R; Brooks, M W; Letvin, N L; Stephans, K F; Wucherpfennig, K W; Hahn, W C; Nadler, L M

Vonderheide, R H; Schultze, J L; Anderson, K S; Maecker, B; Butler, M O; Xia, Z; Kuroda, M J; von Bergwelt-Baildon, M S; Bedor, M M; Hoar, K M; Schnipper, D R; Brooks, M W; Letvin, N L; Stephans, K F; Wucherpfennig, K W; Hahn, W C; Nadler, L M.

Affiliation

Vonderheide RH; Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. rhv@mail.med.upenn.edu

Cancer Res ; 61(23): 8366-70, 2001 Dec 01.

Article in En | MEDLINE | ID: mdl-11731409

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Telomerase / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Res Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links